Janja Pretnar Oblak

1.4k total citations
66 papers, 915 citations indexed

About

Janja Pretnar Oblak is a scholar working on Cardiology and Cardiovascular Medicine, Neurology and Epidemiology. According to data from OpenAlex, Janja Pretnar Oblak has authored 66 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 25 papers in Neurology and 23 papers in Epidemiology. Recurrent topics in Janja Pretnar Oblak's work include Acute Ischemic Stroke Management (21 papers), Cerebrovascular and Carotid Artery Diseases (19 papers) and Cardiovascular Health and Disease Prevention (16 papers). Janja Pretnar Oblak is often cited by papers focused on Acute Ischemic Stroke Management (21 papers), Cerebrovascular and Carotid Artery Diseases (19 papers) and Cardiovascular Health and Disease Prevention (16 papers). Janja Pretnar Oblak collaborates with scholars based in Slovenia, Germany and United States. Janja Pretnar Oblak's co-authors include Marjan Zaletel, Mišo Šabović, Bojana Žvan, Tomaž Pogačnik, Miran Šebeštjen, Senta Frol, Martin Štrucl, T. Kiauta, Monika Turk and Joan Santamaría and has published in prestigious journals such as Clinical Infectious Diseases, Stroke and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Janja Pretnar Oblak

61 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janja Pretnar Oblak Slovenia 17 345 262 257 245 160 66 915
Roger E. Kelley United States 20 294 0.9× 204 0.8× 188 0.7× 245 1.0× 132 0.8× 59 1.0k
Shuji Arakawa Japan 16 337 1.0× 383 1.5× 129 0.5× 272 1.1× 256 1.6× 77 1.2k
Gillian M. Sare United Kingdom 14 205 0.6× 326 1.2× 192 0.7× 146 0.6× 100 0.6× 23 733
Raffi Topakian Austria 21 529 1.5× 579 2.2× 461 1.8× 707 2.9× 138 0.9× 50 1.5k
Peter Vanacker Belgium 14 465 1.3× 501 1.9× 64 0.2× 246 1.0× 189 1.2× 35 1.1k
James Overell United Kingdom 12 618 1.8× 328 1.3× 182 0.7× 658 2.7× 74 0.5× 28 1.3k
Selma C. Tromp Netherlands 17 562 1.6× 179 0.7× 142 0.6× 189 0.8× 69 0.4× 52 1.1k
C. Giannesini France 10 374 1.1× 140 0.5× 119 0.5× 342 1.4× 82 0.5× 15 927
Jin Myoung Seok South Korea 15 281 0.8× 332 1.3× 117 0.5× 220 0.9× 68 0.4× 57 811
Markus Kneihsl Austria 16 304 0.9× 420 1.6× 140 0.5× 227 0.9× 85 0.5× 53 793

Countries citing papers authored by Janja Pretnar Oblak

Since Specialization
Citations

This map shows the geographic impact of Janja Pretnar Oblak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janja Pretnar Oblak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janja Pretnar Oblak more than expected).

Fields of papers citing papers by Janja Pretnar Oblak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janja Pretnar Oblak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janja Pretnar Oblak. The network helps show where Janja Pretnar Oblak may publish in the future.

Co-authorship network of co-authors of Janja Pretnar Oblak

This figure shows the co-authorship network connecting the top 25 collaborators of Janja Pretnar Oblak. A scholar is included among the top collaborators of Janja Pretnar Oblak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janja Pretnar Oblak. Janja Pretnar Oblak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jensen‐Kondering, Ulf, Nils G. Margraf, Slaven Pikija, et al.. (2025). Cerebrospinal Fluid β‐Amyloid and τ Levels in Patients With Iatrogenic Cerebral Amyloid Angiopathy, Sporadic Cerebral Amyloid Angiopathy, Alzheimer Disease, and Controls. Journal of the American Heart Association. 14(15). e041908–e041908.
2.
Frol, Senta, et al.. (2024). Higher efficacy of intravenous thrombolysis in patients with acute ischemic stroke taking direct oral anticoagulants—A new relevant hypothesis. Frontiers in Neurology. 15. 1458697–1458697. 2 indexed citations
3.
Oblak, Janja Pretnar, Katarina Šurlan Popovič, Jawed Nawabi, et al.. (2024). How much of the variance in functional outcome related to intracerebral hemorrhage volume is already apparent in neurological status at admission?. Journal of Neurology. 271(8). 5003–5011. 3 indexed citations
4.
Frol, Senta, Gustavo M Cortez, Janja Pretnar Oblak, et al.. (2024). The evolution of tenecteplase as a bridging agent for acute ischemic stroke. Journal of NeuroInterventional Surgery. 17(2). 117–120.
5.
Oblak, Janja Pretnar, et al.. (2024). Recurrent Intracerebral Haematomas Due to Amyloid Angyopathy after Lyodura Transplantation in Childhood. Neurology International. 16(2). 327–333. 4 indexed citations
6.
Frol, Senta, et al.. (2024). Clinical outcomes of reperfusion therapy in patients with site-specific basilar artery occlusion. Journal of NeuroInterventional Surgery. 17(11). 1249–1253. 1 indexed citations
7.
Frol, Senta, Janja Pretnar Oblak, Mišo Šabović, & Pawel Kermer. (2024). Andexanet Alfa: What We Have Learned from Clinical Trials and Real-World Data. CNS Drugs. 38(3). 163–168.
8.
Oblak, Janja Pretnar, et al.. (2023). A Case Series of Four Patients with Artery of Percheron Occlusion over a Three-Month Period. Neurology International. 15(4). 1352–1358. 1 indexed citations
9.
Frol, Senta, Janja Pretnar Oblak, Mišo Šabović, Pawel Kermer, & Matjaž Sever. (2023). Treatment of Acute Ischaemic Stroke and Concomitant Multiple Arterial Splanchnic Thromboses in a Patient with Immune Thrombocytopenia on Thrombopoietin Agonist: A Case Report. Neurology International. 15(3). 1191–1199.
10.
Frol, Senta, Janja Pretnar Oblak, Mišo Šabović, & Pawel Kermer. (2023). Standard operating procedure for idarucizumab reversal of dabigatran anticoagulation in ischemic and hemorrhagic stroke. Journal of Thrombosis and Thrombolysis. 55(3). 506–518. 2 indexed citations
11.
Frol, Senta, Mišo Šabović, & Janja Pretnar Oblak. (2023). Apixaban for the Treatment of Cerebral Venous Sinus Thrombosis: A Single-Centre Experience and Systematic Review of the Literature. CNS Drugs. 37(2). 133–141. 4 indexed citations
12.
Frol, Senta, Janja Pretnar Oblak, Mišo Šabović, & Pawel Kermer. (2023). Andexanet Alfa to Reverse the Effect of Factor Xa Inhibitors in Intracranial Hemorrhage. CNS Drugs. 37(6). 477–487. 1 indexed citations
13.
Frol, Senta, et al.. (2022). Recurrent Strokes in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Agents. Angiology. 74(4). 344–350. 1 indexed citations
14.
Oblak, Janja Pretnar, et al.. (2021). Preceding Head Trauma in Four Cases of Sporadic Cerebral Amyloid Angiopathy – Case Report Series. Journal of Stroke and Cerebrovascular Diseases. 31(2). 106260–106260. 8 indexed citations
15.
16.
Oblak, Janja Pretnar, et al.. (2020). Mechanical recanalization for acute bilateral cerebral artery occlusion – literature overview with a case. Radiology and Oncology. 54(2). 144–148. 8 indexed citations
17.
18.
Frol, Senta, Mišo Šabović, & Janja Pretnar Oblak. (2020). Re-initiation of anticoagulation after central nervous system hemorrhage during treatment with direct oral anticoagulants: a single hospital cohort study. Neurological Sciences. 42(5). 2005–2012. 1 indexed citations
19.
Gelpí, Ellen, Romana Höftberger, Francesc Graus, et al.. (2016). Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathologica. 132(4). 531–543. 152 indexed citations
20.
Zaletel, Marjan, et al.. (2011). Moyamoya syndrome with arteriovenous dural fistula after head trauma.. PubMed. 50(1). 115–20. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roger E. Kelley Breakdown of academic impact, for papers by Shuji Arakawa Breakdown of academic impact, for papers by Gillian M. Sare Breakdown of academic impact, for papers by Raffi Topakian Breakdown of academic impact, for papers by Peter Vanacker Breakdown of academic impact, for papers by James Overell Breakdown of academic impact, for papers by Selma C. Tromp Breakdown of academic impact, for papers by C. Giannesini Breakdown of academic impact, for papers by Jin Myoung Seok Breakdown of academic impact, for papers by Markus Kneihsl
Rankless by CCL
2026